From the Journals

Autism risk not increased by maternal influenza infection during pregnancy


 

FROM JAMA PEDIATRICS

Maternal influenza infection during pregnancy does not increase the risk for autism spectrum disorder (ASD) in children, according to Ousseny Zerbo, PhD, and associates.

In a study of 196,929 mother-child pairs (the children were born at Kaiser Permanente Northern California between Jan. 1, 2000, and Dec. 31, 2010), 1.6% of the children were diagnosed with ASD. Influenza was diagnosed in 0.7% of mothers during their pregnancy, and 23% received an influenza vaccination during pregnancy.

©Devonyu/thinkstockphotos.com
Of the 1,400 mothers who were diagnosed with influenza, 1.6% of children born in this group were diagnosed with ASD. Risk did not differ significantly according to trimester.

Overall, maternal influenza vaccination did not effect likelihood of ASD diagnosis, with 1.7% of children in this group receiving an ASD diagnosis. A small association between ASD diagnosis and maternal influenza vaccination, however, was seen in the first trimester of pregnancy, with an adjusted hazard ratio of 1.2, translating to a potential extra 4 cases of autism per 1,000 births. But further analysis suggested that this could be caused by bias and chance, and “the association was insignificant after statistical correction for multiple comparisons,” the investigators said.

“While we do not advocate changes in vaccine policy or practice, we believe that additional studies are warranted to further evaluate any potential associations between first-trimester maternal influenza vaccination and autism,” the investigators concluded.

Find the full study in JAMA Pediatrics (doi: 10.1001/jamapediatrics.2016.3609).

Recommended Reading

CDC confirms Zika virus as a cause of microcephaly
MDedge Infectious Disease
Astrovirus MLB2 may cause CNS infection in immunocompromised patients
MDedge Infectious Disease
Primary care management of sepsis survivors does not improve mental health quality of life
MDedge Infectious Disease
Don’t underestimate opioid use in HIV-positive adults
MDedge Infectious Disease
Psychiatric disorders often impair antiretroviral adherence in perinatally HIV-infected teens
MDedge Infectious Disease
Antiretroviral efavirenz linked to increased suicidality
MDedge Infectious Disease
Major depressive disorder increases acute MI risk in HIV
MDedge Infectious Disease
FDA adds lurasidone contraindication to HIV drug labels
MDedge Infectious Disease
Mefloquine labeling falls short on adverse reaction recommendations
MDedge Infectious Disease
Direct-acting antiretrovirals in genotype 1 HCV patients with mental health conditions safe, well tolerated
MDedge Infectious Disease